Sanctuary Advisors LLC Invests $443,000 in Cognex Corporation $CGNX

Sanctuary Advisors LLC acquired a new position in Cognex Corporation (NASDAQ:CGNXFree Report) during the first quarter, according to its most recent disclosure with the Securities & Exchange Commission. The fund acquired 9,033 shares of the scientific and technical instruments company’s stock, valued at approximately $443,000.

Other institutional investors have also added to or reduced their stakes in the company. Royal Bank of Canada lifted its position in shares of Cognex by 13.2% in the 1st quarter. Royal Bank of Canada now owns 200,351 shares of the scientific and technical instruments company’s stock worth $5,976,000 after purchasing an additional 23,326 shares during the period. Empowered Funds LLC acquired a new stake in shares of Cognex during the first quarter worth $291,000. Intech Investment Management LLC increased its position in shares of Cognex by 24.1% during the first quarter. Intech Investment Management LLC now owns 47,444 shares of the scientific and technical instruments company’s stock worth $1,415,000 after buying an additional 9,223 shares during the period. Geneos Wealth Management Inc. raised its stake in Cognex by 402.2% during the first quarter. Geneos Wealth Management Inc. now owns 919 shares of the scientific and technical instruments company’s stock worth $27,000 after buying an additional 736 shares during the last quarter. Finally, Cetera Investment Advisers raised its stake in Cognex by 7.5% during the second quarter. Cetera Investment Advisers now owns 13,208 shares of the scientific and technical instruments company’s stock worth $419,000 after buying an additional 920 shares during the last quarter. 88.12% of the stock is currently owned by institutional investors.

Insider Activity at Cognex

In related news, VP Darren Marc Long sold 20,252 shares of the stock in a transaction dated Wednesday, May 27th. The shares were sold at an average price of $66.34, for a total transaction of $1,343,517.68. Following the completion of the transaction, the vice president owned 3,990 shares in the company, valued at approximately $264,696.60. This represents a 83.54% decrease in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this link. Also, insider Mark Fennell sold 64,873 shares of the firm’s stock in a transaction dated Monday, May 11th. The stock was sold at an average price of $67.05, for a total transaction of $4,349,734.65. Following the sale, the insider owned 11,263 shares of the company’s stock, valued at $755,184.15. This trade represents a 85.21% decrease in their position. Additional details regarding this sale are available in the official SEC disclosure. Over the last 90 days, insiders sold 224,847 shares of company stock worth $14,975,098. 1.70% of the stock is owned by company insiders.

Cognex Stock Performance

Shares of Cognex stock opened at $57.82 on Thursday. The stock has a market capitalization of $9.62 billion, a PE ratio of 68.83 and a beta of 1.49. Cognex Corporation has a 52 week low of $33.45 and a 52 week high of $72.88. The stock has a 50 day moving average price of $64.84 and a two-hundred day moving average price of $55.92.

Cognex (NASDAQ:CGNXGet Free Report) last issued its earnings results on Wednesday, May 6th. The scientific and technical instruments company reported $0.34 earnings per share for the quarter, topping analysts’ consensus estimates of $0.25 by $0.09. Cognex had a return on equity of 10.89% and a net margin of 13.62%.The company had revenue of $268.44 million for the quarter, compared to analyst estimates of $245.98 million. During the same period in the prior year, the firm earned $0.14 earnings per share. Cognex’s revenue for the quarter was up 24.3% on a year-over-year basis. Cognex has set its Q2 2026 guidance at 0.400-0.440 EPS. Research analysts forecast that Cognex Corporation will post 1.48 EPS for the current year.

Cognex Announces Dividend

The firm also recently announced a quarterly dividend, which was paid on Thursday, June 4th. Stockholders of record on Thursday, May 21st were paid a dividend of $0.085 per share. This represents a $0.34 dividend on an annualized basis and a dividend yield of 0.6%. The ex-dividend date was Thursday, May 21st. Cognex’s payout ratio is presently 40.48%.

Analysts Set New Price Targets

CGNX has been the topic of a number of research analyst reports. JPMorgan Chase & Co. raised shares of Cognex from a “neutral” rating to an “overweight” rating and upped their price target for the company from $65.00 to $75.00 in a research report on Tuesday, May 26th. Sanford C. Bernstein reissued an “outperform” rating and issued a $75.00 price objective on shares of Cognex in a research report on Thursday, May 7th. Seaport Research Partners set a $75.00 price objective on Cognex in a research note on Tuesday, May 26th. Weiss Ratings restated a “hold (c)” rating on shares of Cognex in a research report on Friday, May 15th. Finally, Needham & Company LLC raised their target price on Cognex from $67.00 to $75.00 and gave the stock a “buy” rating in a research note on Friday, May 8th. Two analysts have rated the stock with a Strong Buy rating, ten have issued a Buy rating and four have issued a Hold rating to the company. Based on data from MarketBeat, the company currently has a consensus rating of “Moderate Buy” and an average price target of $72.31.

View Our Latest Stock Analysis on Cognex

Cognex Profile

(Free Report)

Cognex Corporation is a leading provider of machine vision systems, software, sensors and industrial barcode readers used to automate manufacturing, logistics and distribution processes. The company designs and develops vision-based products that help manufacturers and logistics operators inspect, identify and guide parts, assemblies and packaged goods in real time. Its solutions are applied in a broad range of industries, including automotive, electronics, semiconductor, pharmaceutical, food and beverage, and general manufacturing.

The company’s product portfolio includes stand-alone vision systems, vision sensors and deep learning-based software platforms that enable automated inspection, quality control and traceability.

See Also

Want to see what other hedge funds are holding CGNX? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Cognex Corporation (NASDAQ:CGNXFree Report).

Institutional Ownership by Quarter for Cognex (NASDAQ:CGNX)

Receive News & Ratings for Cognex Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cognex and related companies with MarketBeat.com's FREE daily email newsletter.